Reumatoid Arthritis (RA) is an autoimmune disorder characterized by peripheral joint inflammation. Recently, an engagement of the brain immune system has been proposed. 1 Both authors contributed equally
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The aim with the current investigation was to study the glial cell activation marker translocator protein (TSPO) in a well characterized cohort of RA patients and to relate it to disease activity, peripheral markers of inflammation and autonomic activity.
Fifteen RA patients and fifteen healthy controls matched for age, sex and TSPO genotype (rs6971) were included in the study. TSPO was measured using Positron emission tomography (PET) and the radioligand [ 11 C]PBR28. The outcome measure was total distribution volume (V T ) estimated using Logan graphical analysis, with grey matter (GM) as the primary region of interest. Additional regions of interest analyses as well as voxel-wise analyses were also performed. Clinical evaluation of disease activity, symptom assessments, serum analyses of cytokines and heart rate variability (HRV) analysis of 24h ambulatory ECG were performed in all subjects.
There were no statistically significant group differences in TSPO binding, either when using the primary outcome V T or when normalising V T to the lateral occipital cortex (p>0.05). RA patients had numerically lower V T values than healthy controls (Cohen's D for GM = -0.21). In the RA group, there was a strong negative correlation between [ 11 C]PBR28 V T in GM and disease activity (DAS28)(r = -0.745, p = 0.002, corrected for rs6971 genotype).
Higher serum levels of IFNγ and TNF-α were found in RA patients compared to controls (p < 0.05) and several measures of autonomic activity showed significant differences between RA and controls (p < 0.05). However, no associations between markers of systemic inflammation or autonomic activity and cerebral TSPO binding were found.
In conclusion, no statistically significant group differences in TSPO binding as measured with
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic, autoimmune inflammatory disease mainly affecting the joints and leading to pain, fatigue and impairment of function (Firestein, 2003) . Several aspects of RA indicate an involvement of neuro-immune pathophysiological mechanisms. An animal model of RA, such as collagen antibody-induced arthritis (CAIA) in rodents was reported to be associated with microglia and astrocyte activation as well as mechanical hypersensitivity (Agalave et al., 2014; Bas et al., 2012) . Tallying these results, collageninduced arthritis (CIA) in mice has been shown to induce increased pain sensitivity and astrocyte activation, both of which were reversed with intraperitoneal anti TNF therapy (Inglis et al., 2007) . There are several reports of pro-inflammatory cytokine upregulation in the spinal cord of arthritic mice (Bao et al., 2001; Lampa et al., 2012a) . Additionally, intrathecal suppression of IL-1 or TNF signalling was shown to hamper arthritis, suggesting interaction between resident cells of the CNS on one hand, and systemic immune regulation on the other (Boyle et al., 2006; Fiorentino et al., 2008) .
Additional support for a neuro-immune link in RA is the cholinergic anti-inflammatory pathway, which is characterized by systemic immune regulation through the vagal nerve (for review, see: ). In RA, decreased parasympathetic (vagal) function has been observed (Bruchfeld et al., 2010) , and there have been indications that neuroinflammatory mechanisms may interact with vagal activity . Importantly, electrical vagus nerve stimulation has previously been shown to reduce experimental arthritis in animals (Levine et al., 2014) and recently, Koopman et al demonstrated that
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vagus stimulation also inhibited systemic TNF production in humans and reduced disease severity in RA patients (Koopman et al., 2016) .
The concept of central nervous system abnormalities in RA disease has been suggested by a number of findings. First, RA has been associated with structural and functional changes in the brain (Flodin et al., 2016; Wartolowska et al., 2012) and cerebral functional connectivity patterns were associated to the degree of systemic inflammation (Schrepf et al., 2018) . Also, longstanding RA disease is associated with central pain sensitization (Leffler et al., 2002) , which is clinically manifested as chronic pain despite adequately suppressed joint inflammation Boyden et al., 2016) . Apart from joint inflammation and pain, RA is also associated with fatigue. Although pain has been shown to have important impact on fatigue (Pollard et al., 2006 ) also central inflammatory mechanisms have been suggested, and TNF-blockade has been shown to reduce RA-associated fatigue to some extent (Yount et al., 2007) . Fatigue is a prominent symptom of the "sickness response"
normally triggered by tissue injury, pain or infections and believed to promote recovery in acute disorders, but if unabated negative long-term effects such as the development of chronic pain have been proposed (Kadetoff et al., 2012; Karshikoff et al., 2016; Watkins and Maier, 2005) . Animal studies show that the sickness response is associated with glia cell activation, and interestingly, IL-1β-dependent sickness behaviour in systemically inflamed rodents has been discussed as a model of human fatigue (Dantzer, 2009 ). In agreement with this, we previously demonstrated a positive correlation between IL-1β in the CSF and ratings of fatigue in RA patients Lampa et al., 2012a) . Furthermore, neuroimmune regulation where activation of the vagus nerve exerts an inhibitory role over the immune system counteracts the systemic "sickness response", reducing cytokine release and attenuating arthritis (Chavan et al., 2017; Koopman et al., 2016) .
One way to study the immune-brain interactions involved in the sickness response in humans is to trigger systemic inflammation by intravenous injection of the endotoxin lipopolysaccharide (LPS). Previous studies have shown that LPS-induced inflammation increased pain sensitivity, spontaneous pain , reduced descending pain inhibition and altered cerebral processing of painful stimuli in healthy individuals, aberrations that were similar to findings in patients suffering from fibromyalgia Karshikoff et al., 2015) . PET studies using radioligands for translocator protein (TSPO) allow for evaluation of glial activity in vivo. Interactions between periphery and CNS have been demonstrated in previous PET studies in humans as increases in cerebral TSPO binding after peripheral LPS-induced acute inflammation (Sandiego et al., 2015) as well as correlations between peripheral and central TSPO binding (Kanegawa et al., 2016) . In addition, Kanegawa et al also showed relationship between the change in [ 11 C]PBR28 binding in brain and periphery comparing two PET measurements at different occasions strengthening the suggested interaction.
In patients, studies using the second generation TSPO radioligand [ 11 C]PBR28, with a better signal-to-noise ratio than prototypic TSPO radioligands (Fujita et al., 2008; Kreisl et al., 2010) , have shown increased cerebral TSPO binding in inflammatory neurological disorders (Herranz et al., 2016; Kreisl et al., 2013b; Zürcher et al., 2015) as well as in patients suffering from chronic low back pain and fibromyalgia (Albrecht et al., 2018a) .
Interestingly, in the fibromyalgia patients a positive association between cerebral TSPO binding and ratings of fatigue was reported, which is in agreement with symptoms of the sickness response (Albrecht et al., 2018a) .
The aim of this study was to evaluate glial activation in RA patients using PET and the TSPO 
MATERIALS AND METHODS

Subjects
Patients with RA, all positive for Anti-citrullinated protein antibodies (ACPA + RA) were recruited through the rheumatology clinic at the Karolinska University Hospital in Stockholm, Sweden. Age and sex matched healthy controls (HC) were recruited through notice board advertisements primarily at the hospital campus and all were physically examined. In total, 15 RA patients and 15 healthy controls were recruited. Baseline characteristics are displayed in Table 1 . All RA patients were ACPA + and fulfilled the ACR 1987 classification criteria for RA (Arnett et al., 1988 Participants were instructed to avoid NSAIDs, alcohol and hard physical exercise two days before PET examinations, to drink coffee as usual and to sleep regularly two days before participation. No other change in medication was allowed the week before PET examination.
All participants were genotyped using provided saliva samples (Tacman SNP genotyping assay) for the genetic polymorphism rs6971 which affects binding to the TSPO radioligand [ 11 C]PBR28, both in vitro and in vivo Kreisl et al., 2013a; . This information was also used for matching of RA and HC according to the genotypes high affinity binding (HAB) and mixed affinity binding (MAB), whereas participants with low affinity binding (LAB) genotype were excluded from further study participation.
Questionnaires
To assess disease activity in the RA patients the composite measure of disease activity score 28 (DAS28) was used. The score is based on the combination of erythrocyte sedimentation rate (ESR), patient global assessment of disease on a 100 mm visual analogue scale (PGA) and the number of swollen (SJ) and tender (TJ) joints at 28 locations (Prevoo et al., 1995) .
A C C E P T E D M A N U S C R I P T DAS28 score was assessed by a trained rheumatologist seeing the patients after completion of the PET scan.
Measures of pain and fatigue were assessed prior to the PET examination. For measurements of pain, participants were asked to rate their overall perception of pain on a 100 mm visual analogue scale (Pain VAS) ranging from "no pain" to "worst imaginable pain" (Huskisson, 1974) . For measures of fatigue participants were asked to rate their perception of fatigue during the last week on a 100 mm visual analogue scale (Fatigue VAS) ranging from "no fatigue" to "worst imaginable fatigue" (Rohekar and Pope, 2009 ). The nine item fatigue severity scale (FSS), known to be able to describe the change of fatigue over time,
was additionally used to assess the state of fatigue in participants (Krupp et al., 1989; Whitehead, 2009 ).
Positron emission tomography (PET) examinations
PET examinations were performed using the High Resolution Research Tomograph (Siemens Molecular Imaging, Knoxville, TN, USA) at the PET centre at Karolinska Institutet, Stockholm, Sweden. For each subject, the PET examination was conducted in the morning/before lunch or just after lunch/afternoon to minimize a possible diurnal influence .
The procedures for [ 11 C]PBR28 preparation, injection and PET data acquisition have been described in detail previously Kanegawa et al., 2016) . Briefly, patients received a radial artery catheter to allow automated arterial blood sampling and a cubital vein catheter in the contralateral arm for intravenous radio ligand administration. Patients were then positioned in the PET system using an individually designed helmet placed in a frame holder as a means of head fixation during the PET data acquisition. The average radioactivity administered was 405 ± 68 MBq (mean ± SD) and 421 ± 36 MBq; with a specific
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radioactivity of 257 ± 228 GBq/µmol and 317 ± 168 GBq/µmol and an injected mass of 0.84 ± 0.50 µg and 0.61 ± 0.33 µg in patients and controls respectively. There were no significant differences in these measures between the groups (p > 0.05). PET data were acquired for 93 minutes.
Arterial input function
Arterial blood was sampled using an automated system (ABSS) for the first 5 minutes.
Manual samples were drawn at 2, 4, 6, 8, 10, 15, 20, 25, 30, 40, 50, 70 and 90 minutes. Preprocessing of arterial blood data was performed using Kaleidagraph 4.1 software (Synergy Software) as described in detail before (Kanegawa et al., 2016) . Correction for radioligand metabolism was performed in PMOD v3.3 (pixel-wise modelling software; PMOD Technologies Ltd., Zurich, Switzerland) using the parent fraction. Individual parent fraction data were fitted using a 3-exponential model.
Image analysis and quantification
Image processing and the definition of ROIs using T1 MR images were performed as described previously Kanegawa et al., 2016) . The primary ROI was brain grey matter (GM). Moreover, an exploratory analysis of additional regions were performed to be able to relate our results to previous findings with [ 11 C]PBR28 in pain disorders (Albrecht et al., 2018a; Loggia et al., 2015) . These regions included: lateral frontal cortex (LFC), lateral parietal cortex (LPC), putamen (PUT), and thalamus. Additionally, ROIs related to vagus nerve induced activation/deactivation, found in various neuroimaging studies, were identified to explore TSPO binding in these specific networks (Chae et al., 2003) . These included one combined ROI of regions related to vagus nerve activation: thalamus, Insula, OFC, temporal pole and cerebellum. Additionally a combined ROI related to vagus nerve
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deactivation included the regions amygdala and hippocampus. In total seven ROIs were investigated.
Quantification of [ 11 C]PRB28 binding was performed using Logan graphical analysis with a metabolite corrected plasma input function to fit the TAC data and estimate total distribution volume (V T ) in each ROI (Logan et al., 1990) . The estimation of V T was based on five frames from 33 to 63 minutes. In addition, for each PET examination a parametric V T image was generated using the stationary wavelet aided parametric imaging (WAPI) approach (Cselényi et al., 2002 ) WAPI analysis of TSPO binding has previously shown to be sensitive to within-subject changes in V T (Jucaite et al., 2015) , and shown good reliability for 63 minute data . In order to compare to previous studies using 
Measures of peripheral inflammation including cytokines
Two vials of blood collected in analysis appropriate tubes during blood sampling prior to the PET scan were directly sent to the central hospital lab at Karolinska University Hospital, Stockholm, Sweden for the respective analysis of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) content.
Prior to, and on the same day as the PET measurements a sample of venous blood was collected. The sample was left undisturbed for 1-1.5h in room temperature and was then centrifuged for either 10 min at 3200g or 20 min at 1500g. Serum was aliquoted and stored
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in -80˚C until use. Cytokine levels in serum samples were measured using the sandwich immunoassay kits human V-PLEX proinflammatory panel 1 (K15049D, Meso Scale Diagnostics) (IFNγ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, TNF-α) and Human V-PLEX MCP-1 (K151NND, Meso Scale Diagnostics) (MCP-1) according to the manufacturer's instructions using overnight incubation at 4˚C. Cytokines were analysed as duplicates on three separate sets of plates. Pairs of matched patient and control samples were always analysed on the same plate. Detection limit values for each respective plate were used to replace any values below the detection limit. Based on findings in previous research the following cytokines were evaluated and related to brain measures of 
Autonomic activity
To assess autonomic activity via heart rate variability a 24h ambulatory recording of ECG (CardioMem CM 4000 multichannel ECG recorder, GE healthcare) was collected for each individual after the completed PET scan. Participants were instructed to follow their normal daily routine, but to refrain from strenuous physical exercise during the period of the ECG recording. All ECG recordings were uploaded to the program CardioDay v2.3.2 (GE Healthcare) where they were visually inspected to ensure correct identification of QRS complexes. Any areas of interference as well as ectopic heart beats were excluded from analysis. To ensure high quality of the resulting HRV parameters ECG recordings were only considered for HRV analysis of time and frequency domain variables if recording length was
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above 20h after quality inspection. ECG recordings from all study participants passed quality inspection.
After power are considered to reflect overall autonomic activity. The SDANN measure is considered to reflect long term HRV components corresponding to ultralow frequency variations in heart rate. The RMSSD has been shown to reflect short term components of HRV corresponding to HF variations in heart rate and both RMSSD and HF measures are considered measures of parasympathetic, i.e. vagal, activity. The LF measure instead reflects low frequency HRV events and is considered a combined measure of both sympathetic and parasympathetic activity while the LF/HF ratio is considered a measure of sympathovagal balance.
Statistical analysis
Differences in V T values for [ 11 C]PBR28 between RA patients and controls were evaluated using repeated measures ANOVA using the age and genotype matched subjects as pairs (IBM Gaussian kernel and averaged Parametric images of V T were then normalized to the custom MRI template based on warping parameters calculated using each individual's T1-w MRI.
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Normalized V T PET images were smoothed with an 8 mm FWHM Gaussian kernel. An explicit mask created by multiplying the mean V T PET image (thresholded at V T > 6) with the
averaged T1-w MRI image (thresholded at intensity > 0.5). To investigate differences in V T between groups in the voxel-based analysis a paired t-test model was created both without global normalization and normalizing each individual brain to its respective V T value in the lateral occipital cortex. The analyses included data for 15 RA patients and 15 healthy controls. Statistical significance at the voxel level was set at p < 0.001 (uncorrected). Clusters with an extent of 50 voxels and p < 0.05 (corrected for multiple comparisons), were considered significant. Statistical maps were corrected for multiple comparisons using cluster level inference derived from random field theory as implemented in SPM.
RESULTS
The demographic information and subject characteristics are presented in Table 1 . As expected RA patients had significantly higher ratings of pain and fatigue and also elevated measures of systemic inflammation. There were no statistically significant differences between the genetically inferred TSPO HAB and MAB groups within the RA cohort regarding VAS pain, VAS fatigue, DAS28 and ESR. CRP was higher in the MAB group compared to HAB in RA patients (3.32 vs 1.41 g/l, p = 0.05). 
RA HC p
Number of subjects 15 15
Demographics Age (y) 51 ± 11.5 50 ± 11.5 0.62
A C C E P T E D M A N U S C R I P T
Sex ( 
PET
All subjects successfully underwent PET examinations using [ 11 C]PBR28. One subject only had 51 minutes of valid PET data but could still be reliably quantified using Logan graphical analysis and parametric imaging could also be performed. Therefore no data was excluded from statistical analyses. The spatially normalized mean images of (Table 2A) . Calculation of effect size revealed a Cohen's D of -0.21 constituting a small effect size (regional effect sizes are shown in Table 2A ). We found significant correlations between V T values in GM and all other ROIs within both cohorts (RA; r  0.982, p < 0.0001, HC; r  0.943, p < 0.0001). DVR showed no statistically significant differences between groups as determined by repeated measure ANOVA utilizing the matched subjects in each group as pairs (F(0.125) = 0.991, p = 0.729) (Table 2B) . 
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Cytokines and measures of peripheral inflammation
The ESR and CRP values are presented in Table 1 
Autonomic activity
As predicted RA patients showed significantly lower values compared to controls in the time 
Correlations between parameters
Partial correlations corrected for genotype or Spearman correlations were calculated evaluating relationships between [ 11 C]PBR28 V T in GM and ratings of pain and fatigue, ESR, CRP and DAS28. We restricted the analysis to GM as we found significant correlations ACCEPTED MANUSCRIPT V T in GM, our primary ROI, and CRP (r = -0.572, p = 0.026)(Spearman correlation), however MAB had higher CRP compared to HAB (p = 0.05). We found a strong negative correlation between [ 11 C]PBR28 V T in GM and DAS28 (r = -0.745, p = 0.002)(partial correlation, corrected for genotype) (Figure 2 ). 
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None of the cytokines or HRV parameters examined showed a significant correlation to global or regional [ 11 C]PBR28 V T values (p > 0.05; data not shown). However, in the RA group a positive correlation (r = 0.69; p<0.01) was observed between serum IL-10 levels and LF/HF, which reflects vagal activity (Stein et al., 1994) . No other significant correlations between cytokines and HRV parameters were found in the RA or HC group.
DISCUSSION
The primary aim of this study was to evaluate the pattern of glial activation in the brain of RA patients compared to age-, sex-and genetically inferred TSPO binding affinity matched healthy controls. Our main hypothesis of increased TSPO binding in patients, to be interpreted as glia activation, was not confirmed. Instead, patients showed consistently
numerically lower values than healthy controls and although a small overall effect size was found (Cohen's D for GM = -0.21), larger effect sizes were seen in several regions for the MAB sub-group. Also, no significant differences were found between RA patients and controls when using DVR with occipital cortex as pseudo reference region (Albrecht et al., 2017) . Our second hypothesis, that higher TSPO binding would be related to increased disease activity was also not confirmed. Instead, we found a strong negative association between TSPO binding and the composite measure of disease activity score 28 (DAS28).
Finally, RA patients had higher serum concentrations of the pro-inflammatory cytokines TNF, IL-6 and IFN, as well as the anti-inflammatory IL-10 and HRV analysis indicated altered autonomic activity, however none of these parameters were associated with TSPO binding.
There are several possible explanations for our unexpected findings. First, experimental studies indicate that TSPO expression does not increase in human microglia following classical pro-inflammatory activation . In fact, in human monocyte-
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derived macrophages, pro-inflammatory activation is even associated with a reduction of TSPO gene expression and TSPO binding sites (Narayan et al., 2018; Owen et al., 2017) .
Therefore, our results of normal, or slightly lower cerebral TSPO binding in RA patients compared to HC, do not necessarily contradict an activation of the proinflammatory type of microglia (or astrocytes). Hypothetically, in accordance with our finding of a strong, negative association between GM TSPO binding and disease activity (DAS28), there may be a shifted balance towards the pro-inflammatory M1-like phenotype of glia in RA. The latter would tally our previous findings of a pro-inflammatory (M1-like) type of cytokine profile in the CSF of RA patients characterized by elevated IL-1β compared to controls (Lampa et al., 2012b) and elevated IL-1β as well as reduced anti-inflammatory cytokines IL-4 and IL-10 compared to the CSF of fibromyalgia patients in which increased cerebral
binding was recently demonstrated (Albrecht et al., 2018a) .
In addition, TSPO may be of pathophysiological significance in other locations than the brain.
Narayan et al. documented an increased [
11 C]PBR28 PET signal in RA joints compared to healthy joints, with increased PBR28 ligand binding in the synovial tissue and the highest TSPO mRNA expression and 3 H-PBR28 binding in fibroblast-like synoviocytes as well as inactivated and M2-like activated, reparative macrophages (Narayan et al., 2018) . Increased TSPO mRNA expression has also been reported in the disc of patients with lumbar disc herniation and was associated with higher intensity of back pain (Palada et al., 2019) and increased TSPO binding was found in the affected nerve roots of patients suffering from lumbar radiculopathy (Albrecht et al., 2018b) . The interaction with the peripheral immune system can be of specific importance in this context, as infiltrating cells may interact with resident CNS cells both by activating and inhibitory actions. Thus it has been shown that interaction between other immune cells, preferably T cells, and microglia may result in anti-
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inflammatory actions (Wang et al., 2016) . Although less is understood regarding the neuroimmune crosstalk between the periphery and CNS, we recently reported neuroimmune blood borne joint-to-CNS signalling in patients with painful osteoarthritis and disc herniation, respectively (Kosek et al., 2018; Palada et al., 2019) . Moreover, we have previously shown that TSPO binding in the brain correlated with TSPO binding in blood cells, as measured using [ 11 C]PBR28 in healthy human subjects (Kanegawa et al., 2016) . In order to understand In line with RA being a chronic inflammatory disease (Hueber et al., 2007) , we observed increased levels of CRP, ESR as well as several pro-inflammatory cytokines in RA patients including TNF-α, IFNγ and IL-6. However, a significant association to cerebral TSPO binding was found only for CRP. The negative correlation between CRP and [ 11 C]PBR28 VT in GM was most likely explained by the significant difference in CRP between the genotypes as MAB had higher CRP and lower cerebral TSPO binding compared to HAB. Interestingly RA patients also displayed a higher serum level of IL-10 which is considered immunoregulatory.
Increased IL-10 levels have previously been described in both systemic lupus erythematosus (SLE) and RA and have been considered on the one hand to be an effect of B-and T cell hyperactivity or on the other hand as a result of increased levels of circulatory monocytes in
the dysregulated immune response of these autoimmune diseases (Al-Janadi et al., 1996; Tsukamoto et al., 2017) .
Furthermore, RA patients have frequently been described as having decreased parasympathetic (vagal) activity and increased heart rate (Aydemir et al., 2010; Goldstein et al., 2007; Stojanovich et al., 2007) , which we were able to confirm in the present study.
Autonomic activity and immunity are closely interconnected as illustrated by the vagus dependent cholinergic anti-inflammatory pathway, the proposed efferent arm of the inflammatory reflex, which is impaired in several autoimmune diseases including RA (Huston and Tracey, 2011) . Associations between autonomic activity and inflammatory mediators has been demonstrated by Goldstein and co-workers showing a negative correlation between serum levels of High mobility group box-1 (HMGB-1) and HF measures of autonomic activity (Goldstein et al., 2007) . Interestingly, in the present study, we found a positive correlation between IL-10 levels in the RA group and LF/HF (r = 0.69; p < 0.01). This correlation between vagal activity and an anti-inflammatory cytokine is in line with previous data showing inverse correlation between pro-inflammatory IL-6 in serum and LF measures of autonomic activity and corroborates the concept of suppressed autonomic function in RA due to systemic inflammation effects. In order to assess if HRV measures of autonomic activity were associated with cerebral TSPO binding, we chose to assess two ROIs that had been related to vagus nerve induced activation and deactivation, respectively (Chae et al., 2003) . However, as previously stated, no statistically significant associations were found between the PET [ 11 C]PBR28 binding in these ROIs and the assessed measures of autonomic activity.
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Limitations
It is known that the relatively high test/retest variability of [ 11 C]PBR28 together with the need of controlling for the genetically determined binding affinity to TSPO Owen et al., 2012) requires fairly large cohorts for a study to be sufficiently powered, and it cannot be excluded that our study may have been too small to detect any significant differences between patients and control subjects. To allow for paired comparisons, and therefore increased power, we matched our controls not only according to sex and age, but also genotype. Furthermore, in order to reduce variability, ratio-based approaches such as standardized uptake ratio (SUVr) and distribution volume ratio (DVR) have been employed in clinical studies using [ 11 C]PBR28 (Albrecht et al., 2017; Kreisl et al., 2013b; Loggia et al., 2015; Lyoo et al., 2015) . In healthy control subjects, these approaches have shown poor reliability and low correlation to the standard outcome measure V T (Matheson et al., 2017 ) whereas Albrecht and colleagues were able to show increases in both DVR and V T in subjects with chronic low back pain compared to controls (Albrecht et al., 2017 ) and the two methods of analysis were found to correlate in a combined group of fibromyalgia patients and healthy controls (Albrecht et al. 2018) . In our study, we found no difference using either V T or DVR values calculated with the pseudo reference region occipital cortex. Thus, our results of no increases in TSPO binding in RA patients compared to HC were confirmed using both methods of analysis.
The RA disease is based on several diagnostic criteria and associated with a potential large heterogeneity concerning numbers of, and kind of joints affected. In order to minimize heterogeneity we included only ACPA positive patients in the study. In addition, the included patients all experienced fatigue, which has earlier been considered as a symptom related to pain and CNS neuroinflammatory features (Norheim et al., 2011) . Furthermore, we cannot
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exclude the influence of medications, given that 80% of our patients were treated with biologics. For example, TNF inhibitors, taken by 60% of our patients could have hampered glia activity, as has been shown in animal models of RA (Inglis et al., 2007) . For ethical reasons we could not alter the anti-rheumatic treatments of our patients but we requested them to refrain from NSAIDs 48 hours before PET scans and excluded patients on oral steroid medications. NSAID treatment, used by 40% of our patients was earlier shown to suppress activated microglia in animal models of Alzheimer's disease (Yan et al., 2003) . The effect of NSAID usage in the present study should however be limited since only one patient was treated on a regular basis, and no NSAIDs were allowed within 48 hours of the PET examination. However, as the drugs are expected to reduce, and not to increase, disease activity, our finding that lower disease activity was related to higher TSPO binding would argue against medication effects as an explanation for the lack of increased TSPO binding in RA patients compared to controls. Also, given the negative association between DAS28 and cerebral TSPO binding, our results cannot be explained by low disease activity in our patients (7 patients had DAS  3.2, i.e., low disease activity).
Conclusion
We found no statistically significant group differences between RA patients and HC in TSPO binding as measured with [ 11 C]PBR28 PET. However, within the RA group, there was a strong negative association between cerebral TSPO binding and disease activity, suggesting that cerebral TSPO might relate to protective, disease modifying effects in RA. We did not find any associations between measures of systemic inflammation or autonomic activity and cerebral TSPO binding. In light of the earlier confirmed neuro-immune features of RA, these
A C C E P T E D M A N U S C R I P T results warrant further investigations regarding neuro-immune joint-to-CNS signalling in
order to open up for potentially new treatment strategies.
Acknowledgements
The authors thank the staff of the Karolinska Institutet PET centre for excellent technical assistance. We also thank K. Sahlander, N. Knave, G. de Forest, M. Dahl, B. Engvall, B.
Dahlberg, M. Ahlsén, S. Tamm, S. Martinsen, P. Hakeberg, R. Altawil for help with data collection. Albrecht, D., Forsberg, A., Sandstrom, A., Bergan, Courtney, Kadetoff, D., Protsenko, E., Lampa, Jon, Lee, Y., Olgart Höglund, C., Catana, C., Cervenka, S., Akeju, Oluwaseun, Lekander, M., Cohen, G., Halldin, Christer, Taylor, N., Kim, M., Hooker, Jacob, Edwards, R., Napadow, V., Kosek, Eva, Loggia, M., 2018a. Brain glial activation in fibromyalgia -a multi-site positron emission tomography investigation.
Funding and disclosure
A C C E P T E D M A N U S C R I P T 
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T
